Lingqing Ding

Statistics

Publications

Citations

H-Index

Active since

2022

Affiliations

First Affiliated Hospital of Xiamen University(Current)

Lingqing Ding is an author at First Affiliated Hospital of Xiamen University specializing in proportional reporting ratio, pharmacological treatment of dementia, and multi-item gamma poisson shrinker.

Publications per year

2022–2024

Publications

Updated insights on <scp>dementia‐related</scp> risk of sacubitril/valsartan: A <scp>real‐world</scp> pharmacovigilance analysis

Congqin Chen, Lingqing Ding, Fang Fu et al. · CNS Neuroscience & Therapeutics · 2023 · 37 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Major cardiovascular events under biologic psoriasis therapies: a 19-year real-world analysis of FAERS data

Lingqing Ding, Congqin Chen, Y. Yang et al. · Frontiers in Immunology · 2024 · 23 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Booster dose of COVID-19 mRNA vaccine does not increase risks of myocarditis and pericarditis compared with primary vaccination: New insights from the vaccine adverse event reporting system

Congqin Chen, Fang Fu, Lingqing Ding et al. · Frontiers in Immunology · 2022 · 14 citations · Full text

Veterinary Medicine, Cardiology, Infectious Diseases +17

1–3 of 3